Validated life sciences configuration
GxP patterns, electronic signatures, validated workflows, and regulated retention ship as starting configuration rather than bespoke work.
OpenText • Content services
Documentum Content Management for Life Sciences (formerly OpenText Document Management for Life Sciences) is OpenText's validated configuration of the Documentum platform for pharma, medical devices, and regulated life sciences programs and 21 CFR Part 11, EMA Annex 11, clinical content, manufacturing documentation, and regulated submissions.
Validated workflows and electronic signatures come first, then clinical and GxP manufacturing content patterns, with Merito working alongside your quality and validation teams on the validation documentation.
What it is
OpenText Documentum Content Management for Life Sciences is the pre-configured regulated industry edition of the Documentum platform for pharma, medical devices, and life sciences programs. It ships validated patterns for 21 CFR Part 11 and EMA Annex 11 compliance, regulated submission processes, clinical content management, controlled manufacturing documentation, and quality management processes that would otherwise require extensive custom configuration.
The regulatory posture is its defining property. The FDA and EMA have accepted Documentum-based content programs in pharma and med-device validations for decades. New regulated programs that start from Documentum Content Management for Life Sciences inherit that posture rather than building compliance evidence from scratch.
Validation is central to adoption. Every configuration change, every integration, every workflow lands in the validation documentation that the FDA or EMA can audit. Merito's Documentum Content Management for Life Sciences engagements include validation partnership with the customer's compliance function as a tracked workstream, not an afterthought.
Ideal use cases
What it is best at
GxP patterns, electronic signatures, validated workflows, and regulated retention ship as starting configuration rather than bespoke work.
Decades of deployed pharma and med-device validations. The regulatory posture is known to regulators worldwide.
D2 and xCP frameworks let regulated programs embed program-specific processes without breaking compliance patterns.
Core capabilities
GxP content lifecycle from authoring through retention.
Controlled authoring
Validated authoring workflows with version control and state transitions.
Electronic signatures
21 CFR Part 11 and EMA Annex 11 electronic signatures.
Regulated retention
Retention schedules aligned with FDA, EMA, and jurisdictional life-sciences requirements.
Patterns for clinical operations and manufacturing documentation.
Clinical trial master file
Trial master file organization and access aligned with clinical trial processes.
GxP manufacturing documents
Standard operating procedures, batch records, and controlled manufacturing documentation.
Quality management content
CAPAs, deviations, and quality management document workflows.
Content lifecycle for regulated submissions and submission management.
Submission content organization
Content organized for electronic submission preparation.
Submission workflow
Review, approval, and readiness workflows for regulated submissions.
Post-submission lifecycle
Content lifecycle after submission, including inspection readiness.
Where it fits in the stack
Deployment and implementation
Licensing and packaging
Documentum Content Management for Life Sciences standard
Validated configuration for clinical, manufacturing, and submission content programs.
Best for: Pharma, medical device, and life sciences programs.
Merito services
Pick the engagement that matches where you are in the lifecycle.
Validated workflow design, electronic signature configuration, GxP patterns, and validation documentation partnership.
Explore serviceDocumentum platform version upgrades and migration from legacy regulated ECM preserving validation history.
Explore serviceNamed engineer, priority SLAs, and release-time coverage for regulated life-sciences operations.
Explore serviceLong-term run support including validation maintenance as configurations evolve.
Explore serviceDocumentum Content Management for Life Sciences licensing
Moving regulated content off Documentum means rebuilding the validated posture, and modernizing the hosting usually costs less.
Merito point of view
Moving regulated pharma content off the Documentum platform onto newer products usually costs more in rebuilt validation than it saves in platform modernization. For regulated life sciences, Documentum Content Management for Life Sciences usually remains the right call. Modernization happens at the hosting layer (containerized deployment, private cloud) rather than at the application layer.
For content that is not regulated (marketing, general corporate), Content Management could be the right modernization target. Customers often run both. Documentum Content Management for Life Sciences for regulated content, Content Management for everything else, with Merito coordinating the split.
Validation work is the hidden cost that matters most. Programs that treat validation as an afterthought spend more time on validation rework than on implementation. Merito's engagements build validation into every workstream.
What buyers usually underestimate
Related from Merito
Related solutions
Related services
Related products
Frequently Asked Questions
Consultation request
Share your regulated program scope (clinical, manufacturing, submissions) and validation approach. A Merito life sciences content specialist follows up within one business day.
Validated patterns
Life sciences configuration ships validated workflows, signatures, and retention as starting configuration.
Validation as workstream
Merito makes validation a tracked workstream from day one with the customer's compliance function.
Next step
A Merito life sciences engagement makes validation a tracked workstream from day one, not a retrofit.